Your doctor can tell you what they think of the last ten years of clinical trials.
My opinion is that everything in stroke is a complete failure. No objective diagnosis, tPA is a failure, F.A.S.T. is a failure, hyperacute rehab is a failure because there isn't any, acute rehab has failed, chronic rehab is a colossal failure with only 10% full recovery. All my opinion with no medical background. Its better to not a have a medical background because then you don't make excuses for all the failures. I dare anyone to tell me where I'm wrong, quote studies and statistics, not personal anecdotes. What outcomes reached would be considered not a failure?
http://scholar.google.com/scholar_url?hl=en&q=http://www.sjzsyj.org:8080/Jweb_sjzs/CN/article/downloadArticleFile.do%3FattachType%3DPDF%26id%3D606&sa=X&scisig=AAGBfm2v0qyb_fu7jc5w2xUU9HJlvXs5mQ&oi=scholaralrt
INTRODUCTION
Stroke is one of the most common refractory diseases, and has serious consequences for human health and safety. It is estimated that there are nearly 2 million stroke patients in China each year. The incidence of stroke is as high as 201/100 000; there are 7 million surviving stroke patients, 4.5 million of whom have varying degrees of work incapacity or cannot take care of themselves and with high disability rate.
Patients would like to recover as soon as possible after stroke. Scientists also would like to see their discoveries help people with stroke. Physicians, surgeons and therapists want the treatments they provide to improve an individual’s independence, mobility and quality of life.
Clinical trials is a very important way to improve the level of treatment, it can determine if a promising stroke rehabilitation treatment is safe and effective for patients, and can be approved by the regulatory authorities. With respect to the treatment and rehabilitation on stroke patients, these trials may evaluate drugs already approved for other diseases to assess if the drug may be useful for stroke rehabilitation. They may also evaluate new experimental drugs to determine if they improve motor function, recovery of linguistic function, slow disease progression or even prevent stroke for patients following stroke.
In this paper, a quantitative analysis was conducted to investigate programs registered in the National Institutes of Health (NIH) Clinical Trials registry (ClinicalTrial.gov) for quantitative analysis of stroke rehabilitation treatment research. We also collected data from the Web of Science database on research funding bodies and trials on stroke rehabilitation to provide an understanding of international research trends in stroke rehabilitation treatment over the past 10 years.
No comments:
Post a Comment